PMDA inspection
Novartis Pharma AG
PMDA inspection 5130508040465 · Switzerland · Suitable
Key facts
| Control number | 5130508040465 |
|---|---|
| Manufacturing site | Novartis Pharma AG |
| Location | Lichtstrasse35, CH-4056 Basel, Switzerland |
| Country | Switzerland |
| Product type | Pharmaceuticals |
| Application type | Complete Change |
| Inspection method | Remote |
| Inspection month | Sep 1, 2024 |
| Result | Suitable |
| Result notified | Sep 25, 2024 |
| PMDA registration | AG21500066 |
About PMDA GMP inspections (Japan)
Japan's PMDA conducts GMP and QMS inspections of domestic and foreign manufacturing sites that supply the Japanese market.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan